检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]浙江中医药大学,浙江杭州310053 [2]南京中医药大学江阴附属医院,江苏江阴214400
出 处:《中华中医药学刊》2016年第11期2741-2744,I0010,共5页Chinese Archives of Traditional Chinese Medicine
基 金:浙江省中医药科技项目(2010ZB151)
摘 要:目的:确定祖师麻总香豆素缓释片的处方,并评价其体外释药特征。方法:采用羟丙基甲基纤维素(HPMC K4M)为骨架材料,乳糖为填充剂,在处方单因素考察的基础上,选择对缓释片释放行为影响较大的2个处方因素—HPMC用量和乳糖用量,以累积释放度为指标,利用星点设计-效应面法优化处方,并评价释药特征。结果:最优处方组成为祖师麻总香豆素200 mg,HPMCK4M为80 mg,乳糖60 mg,MCC60 mg;其在2、6、12 h的体外累积释放度均值分别为31.41%、60.85%、81.56%,满足缓释片释放要求;缓释片体外释放符合Higuchi方程,释放机制为扩散和骨架溶蚀的双重机制。结论:本方法制备的祖师麻总香豆素缓释片工艺简单易行,具有较好的缓释性能。Objective : To prepare sustained - release tablets of total conmarins from Daphne giraldii and investigate its release in vitro. Methods: The sustained -release tablets were prepared with HPMCK4M as the skeleton material,lactose as the filler. On the basis of single - factor investigation and taking cumulative release percentage degree as index, the for- mulation of the tablets was optimized by central composite design -response surface methodology( CCD -RSM) for 2 fac- tors(amount of HPMCK4M and amount of lactose). And the releasing mechanism of the tablets was investigated. Results: The most desirable formulation included 200 mg total coumarins,80 mg HPMC K4M,60 mg lactose and 60 mg microcrystalline cellulose. The average accumulated release rates of the sustained - release tablets in 2,6 and 12 h were 31.41% ,60.85% and 81.56%, meeting the requirements for sustained -release tablets. The release in vitro followed the Higucbi equation. The release behavior in vitro could be controlled by diffusion associated with erosion. Conclusion: The sustained - release tablets of total coumarins from Daphne giraldii prepared by this method have good release charac- teristics. The formulation and preparation are reasonable, practical and suitable for manufacturing industries.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15